SLC5A2 and lactic acidosis: The patient's clinical presentation suggested a UTI accompanied by an anion gap metabolic acidosis, possibly secondary to lactic acidosis stemming from UTI-related sepsis or euDKA secondary to empagliflozin, an SGLT2 inhibitor.